A B S T R A C T Hydrocortisone sodium succinate (SoluCortef; Upjohn Co., Kalamazoo, Mich.) has been found to induce choleresis in unanesthetized fasting dogs fitted with Thomas duodenal cannulae for direct quantitative collection of bile. In all experiments, bile flow increased (average, 68%) 15-20 min after beginning hydrocortisone by infusion in association with an equivalent increment in the output of sodium, potassium, chloride, and bicarbonate. In five animals, the choleretic response occurred independently of, and apparently additive to, the effect of simultaneously administered sodium taurocholate. The fluid added to the bile resembled an ultrafiltrate of plasma. Erythritol clearance increased in proportion to flow, suggesting an effect at the hepatocellular rather than ductal level and probably independent, therefore, of endogenous secretin release. Hydrocortisone and its metabolites were excreted in amounts too small to induce choleresis osmotically. Simultaneous administration of sulfobromophthalein sodium blocked the choleretic response without preventing hydrocortisone excretion. The data suggest that a previously ill-defined mechanism of canalicular bile formation, not mediated by bile salt excretion, may be operative in choleretic response to a variety of agents.
INTRODUCTION
The physiologic effects of the acute administration of adrenocortical steroids on the normal liver are not well-defined. Studies in man (1) (2) (3) (4) Received for publication 13 February 1970. cortisone. These disparate results may reflect differences in methods of bile collection or patient selection rather than differing responses to the same hormone. A marked sensitivity of hepatobiliary secretory mechanisms to a variety of other steroid compounds has been amply demonstrated. Active secretion of primary bile salts, for example, has long been known to provide a major impetus for bile formation in most species (5) . In contrast, some steroids (estrogens, androgens, secondary bile acids) have deleterious effects upon hepatic excretory function (6) (7) (8) (9) .
Systematic evaluation of the influence of adrenocortical steroids on biliary composition and flow in normal experimental animals appears to be lacking (10) (11) (12) . In the studies presented herewith, the effects of intravenous hydrocortisone on bile formation during constant taurocholate infusion have been explored in unanesthetized dogs equipped with duodenal cannulae. The results indicate that hydrocortisone is highly active in stimulating a choleresis that is canalicular in origin and independent of bile acid secretion.
METHODS
All studies were made in five healthy unanesthetized adult dogs (16-30 kg) which had undergone cholecystectomy and installation of a Thomas duodenal cannula at least 8 months before the present studies. Before each experiment the animal under study was fasted for 24 hr. The common bile duct was then catheterized under direct vision with a No. 6 olive-tipped ureteral catheter. Thereafter, the dog was maintained in the upright position with the aid of a sling. Bile samples (3.5-4 ml) were collected by gravity in graduated centrifuge tubes.
Throughout all studies, a 1.3% solution of sodium taurocholate (Nutritional Biochemicals Corporation, Cleveland, Ohio) was infused (Bowman pump, Bowman Electrical Products Corp., Chicago, Ill., at a constant rate of 10-12 /LEq/min) through a No. 17 Deseret polyethylene catheter in a foreleg vein. Pipenzolate methylbromide1 (Piptal) was also given intravenously (2 mg every 5 min during the ist hr and every 10 min thereafter) to diminish spontaneous 1 Supplied by the Lakeside Laboratories through the courtesy of Dr. Joseph A. Skorcz. variations in bile flow (13) . Each experiment consisted of a control period of 60 min, a period of about 1 hr when 200 mg of hydrocortisone sodium succinate (Solu-Cortef) in 50 ml of normal saline were administered intravenously, and two 60-min recovery periods. When plasma samples were obtained, they were drawn through a polyvinyl catheter (Vx 044 BD) in one of the saphenous veins.
On three occasions sodium taurocholate-24-'4C (Tracerlab Div., LFE Electronics, Richmond, Calif.) was added in tracer amounts to the taurocholate infusion and infused at a rate of about 0.35 ,uCi/min. Biliary excretion of the labeled bile salt was calculated from the product of the concentration (dpm/ml) and the bile flow (ml/min). Since the hepatic extraction of sodium taurocholate at this rate of infusion has been shown to approximate 100% (14) , the hepatic plasma flow was estimated by calculation of the biliary clearance, CB, of the tracer by the formula CB = BV/A where CB = biliary clearance, ml/min; BV = biliary output of the tracer, dpm/min; and A = the plasma concentration of the labeled bile salt, dpm/ml.
In four experiments hydrocortisone-4-14C (New England Nuclear Corp., Boston, Mass., SA, 0.1 mCi/0.0697 mg of hydrocortisone) was infused with the unlabeled hydrocortisone at a rate of 0.1 'ACi/min. The recovery of the tracer was measured in bile and urine samples which were collected simultaneously. Urine samples were obtained through a Bardex Four Wing Malecot catheter which had been passed into the urinary bladder under local anesthesia.
During three studies erythritol-'4C (Amersham-Searle) was administered at a rate of about 0.3 ,uCi/min after an initial priming dose of 3 ,4Ci. An equilibration period of at least 60 min was followed by the usual control and hydrocortisone infusion periods. Further collection of plasma and bile samples was continued for only a single recovery period. Clearance values during all three periods were calculated as for bile salt as noted above.
Measurements of sulfobromophthalein sodium (BSP, Hynson, Westcott & Dunning, Inc., Baltimore, Md.), transport maximum (Tm), and relative storage capacity (S) during control, hydrocortisone infusion, and recovery (R1) periods were made on five occasions (four dogs) 1 hr after the BSP infusion (5-10 mg/min) had begun. In addition, all dogs received an initial prime of 8 mg/kg. Plasma samples were drawn every 5 min, and bile samples collected every 10 min. Tm (mg/min) was taken as the biliary output (mg/min) of BSP as long as the plasma concentration remained in excess of 3 mg/100 ml. The relative storage capacity, S(mg/mg per 100 ml), was estimated as follows: pected as a result of dead space effects and depletion of the endogenous bile acid pools during complete collection of bile, suggests that the hormone had no direct effect upon biosynthesis or intestinal absorption. In order to define more precisely the hepatic excretion and clearance of bile acids, sodium taurocholate-4-14C was added to the taurocholate infusion at the beginning of the experiment in each of three dogs. The biliary output of radioactivity remained constant throughout in conformity to the indirect determinations. Since the extraction of taurocholate by the canine liver is close to 100% when it is administered in doses (10) (11) (12) isEq/min) comparable with those employed in these studies (14) , it may be inferred that the hepatic clearance of labeled taurocholate may be used as a reliable estimate of hepatic blood flow. The constancy of labeled taurocholate clearances under these circumstances throughout each of these three experiments therefore indicates little or no change in hepatic perfusion and in consequent delivery of bile acids or other substances to the liver as a result of such a change.
It should be stressed that the choleresis produced by hydrocortisone appeared to be superimposable upon that attributed to taurocholate excretion (Fig. 2) . The extent to which this response was strictly additive cannot be defined at this point owing to the intrinsic variance in bile flow, unpredictable differences in control values for flow from animal to animal and from time to time in the same animal, and uncertainties regarding the hydrocortisone dose-response relationship. In two experiments, taurocholate was infused at successively higher rates (10, 45, and 90 AEq/min) to determine the bile flow-taurocholate output relationship. Bile flow increased with each increment in taurocholate infusion to reach an equilibrium after about 60 min at each rate (shown as closed circles in Fig. 2) . These measurements were then repeated during constant hydrocortisone infusion (4 mg/min; open circles in Fig. 2 ). In one animal (C) the taurocholate infusion was successively reduced from 90 to 45 to 10 /Eq/min. In the other (R) the taurocholate infusion was reduced to 10 *Eq/min and then increased successively to 45 and 90 /zEq/min. Each measurement Table I. and electrolyte output Tau-, were obtained as was made after 60 min of equilibration. It may be seen in Fig. 2 that hydrocortisone always increased bile flow above levels produced by taurocholate regardless of the rate of taurocholate infusion or antecedent bile flow rate. Table III . It may be seen that radioactivity was largely eliminated in both urine and bile. Labeled material appeared in the bile in measurable amounts within 30 min in each study. The plasma radioactivity tended to "level off" for a period of approximately 1 hr shortly after completion of injection or infusion and declined slowly thereafter. Calculation of biliary clearances during this "equilibrium period" yielded mean values of 56.0 ml/min for dog R, 45.0 ml/ min for dog M, 41.0 ml/min for dog G, and 14.0 ml/min for dog C in association with bile flows of 0.23, 0.18, 0.34, and 0.17 ml/min, respectively. It should be noted that bile flow increased significantly in all except the animal (dog M, see above) that received a tracer dose only of the steroid. Bile and urine samples obtained during the "equilibrium period" in two dogs (M and G) were subjected to paper chromatography and strip radioscanning to evaluate metabolic changes in hydrocortisone-4-'C dur- ing the stay in the body. The radioactivity in samples of both bile and urine was found to move preponderantly as a single band, having Most, if not all, of the substance excreted in bile was, therefore, a derivative of the infused steroid. The small amount of unaltered steroid appearing in the urine was concentrated by methylene chloride extraction to permit more precise chromatographic identification. The bile acids (Rr 0.70) interfered with extraction from bile. Erythritol excretion. To assess the effect of hydrocortisone upon the excretion of small, metabolically inert molecular species such as creatinine, urea, and mannitol, the clearance of erythritol-14C was measured before, during, and after administration of the steroid in three dogs.
The average clearance values during 1 hr of control measurements ranged from 0.19 to 0.24 ml/min (Fig. 3) in association with bile/plasma concentration ratios of 1.35 in dog C, 1.71 in dog G, and 2.13 in dog A. These findings conform to earlier observations made in dogs receiving taurocholate at the same infusion rate (10 AEq/min) (16) . The clearances increased 33-72% during hydrocortisone choleresis in all three animals. Maximal clearances (measured over 15 min or more) ranged from 0.29 to 0.41 ml/min (Fig. 3) . These changes were proportional to those in bile flow so that bile/plasma Sodium Taurocholate concentration ratios remained relatively constant (1.42-G, 1.55-C, 2.04-A). Although taurocholate infusion was kept constant throughout, the response was similar to that observed when taurocholate infusion was increased two-to threefold in other studies (13) . Sulfobromophthalein sodium (BSP) excretion. The biliary excretion of BSP was evaluated on five occasions before, during, and after administration of hydrocortisone infusion as a guide to the effect of the hormone upon hepatocellular function. Values for relative storage capacity (S) and maximal transfer rates (T.) of BSP are presented in Table IV . No obviously consistent change was observed. Maximal transport decreased slightly in three experiments and increased somewhat in two. Storage capacity varied widely, increasing markedly in one experiment, decreasing in a second, and changing relatively little in three more. In one experiment (Fig.  4) , hydrocortisone-4-14C was added to the infusion of Solu-Cortef. The presence of BSP appeared to have no clearly demonstrable effect upon biliary clearance (29.0 ml/min) of the isotope. It is noteworthy, however, that the choleresis associated with maximal excretion of BSP was not further augmented, as expected, during administration of hydrocortisone (Table IV and 
DISCUSSION
These experiments have clearly defined a major choleretic action of hydrocortsione in the dog. Although the administered dose of glucocorticoids was high relative to body weight (equivalent to about 10 mg of hydrocortisone per kg) choleresis began when considerably less than half of the total dose had been infused. In two experiments a similar choleretic response was observed with a total dose of only 50 mg of hydrocortisone by infusion over 1 hr. A response does seem to occur, therefore, at dosage levels which are not greatly in excess of maximal rates of cortisol synthesis reported (18) for the dog. The data are insufficient, however, to warrant the conclusion that adrenal steroids exert an influence upon hepatobiliary function under normal physiologic conditions. According to the current view (5), bile is secreted by the hepatic cells into the canaliculi by a mechanism dependent, in the main, upon bile salt excretion. A second moiety of fluid and electrolyte is believed to be added by the ducts and ductules under the influence of secretin (13) . Additional support for this hypothesis has emerged from recent studies (16, 19) of the biliary clearances of a variety of metabolically inert, lipid insoluble, and high diffusible solutes of relatively small molecular dimensions (including urea, creatinine, mannitol, and erythritol). All appear to be distributed rapidly and equally between the plasma and the hepatic cells, all are cleared at approximately the same rate, and all are correlated linearly with taurocholate excretion. In contrast, secretin choleresis does not affect inert solute clearance in keeping with the inference that the bile salts control canalicular flow, and biliary volume may be modified by fluid transfer more distally.
The maximal increment in bile formed after administration of hydrocortisone resembled that produced in response to the additional excretion of 10-12 ILEq of sodium taurocholate per min (Table V) . Its composition, computed by dividing the increment in output of each constituent by the increment in flow, was similar to that of plasma water except for a somewhat high bicarbonate concentration. Since studies with isotopically labeled hydrocortisone failed to show any cleavage of the steroid nucleus, only the cationic free or conjugated forms appear to have been present. Consequently, biliary output of the hormone appeared to amount to no more than 1-2 /AEq/min. This excretion of hormone did not change even when the expected increase in bile flow was eliminated during maximal excretion of BSP. In view of this fact and the absence of additional taurocholate excretion, the bile flow increment was probably not the result of an osmotic gradient imposed at the canalicular level by either hydrocortisone or bile salt per se.
It is possible that the changes observed in biliary volume and composition could have been induced by a secondary rise of endogenous secretin levels. In line with this possibility, hydrocortisone is known (20) to induce gastric acid secretion, a potent stimulus to secretin release. With secretin, however, a much more alkaline and more concentrated maximal increment would have been expected (13) . Moreover, the erythritol clearance increased with bile flow during the action of hydrocortisone resembling, in this respect, the response to taurocholate rather than the response to secretin (16, 19) . The alteration in erythritol clearance strongly suggests that hydrocortisone acts at the hepatocellular level. Although hepatocellular transport and accumulation of BSP were not affected by hydrocortisone in these experiments, maximal BSP excretion did apepar to prevent hydrocortisone choleresis independently of steroid clearance (Fig. 4) . These findings are consistent with a mechanism of canalicular choleresis which is independent of the cellular transport of BSP or hydrocortisone as such.
Although canalicular bile formation may depend importantly upon active transport of bile acids and other organic anions, the failure of changes in bile acid output (BV) to affect canine bile flow at very low absolute levels of BV (21) and the positive intercept for mannitol clearance (Cm) when Cm is plotted against BV in the dog (16) indicate that other mechanisms may also play a primary role. The present study suggests that such a mechanism is activated by hydrocortisone. The data are consistent with an increase in bile flow as the result of the addition of an iso-osmotic ultrafiltrate of plasma, possibly secondary to a change in the permeability of an intercellular barrier between plasma and bile. The choleretic responses to hydrocortisone and taurocholate appear to be independent and additive ( Fig. 2) and may, therefore, depend upon different canalicular mechanisms. Furthermore, the observed interaction between BSP and hydrocortisone, but not between either and taurocholate, indicates that certain organic anions may not share in toto the secretory pathway for taurocholate, a conclusion in harmony with recent work by Alpert, Mosher, Shanske, and Arias (22) on Corriedale sheep in which BSP transport is impaired independently of bile acid transfer. More work is necessary to define the extent to which biliary hydrocortisone secretion and its choleretic effect may be generally representative of biliary excretion of other organic cations or anions (23) . Such a mechanism of taurocholateindependent choleresis may well be involved in producing inexplicable variations in basal bile flow under a wide variety of conditions and in the beneficial response to steroid therapy sometimes observed (24) in patients with intrahepatic cholestasis.
